292 related articles for article (PubMed ID: 23518709)
1. Safinamide and flecainide protect axons and reduce microglial activation in models of multiple sclerosis.
Morsali D; Bechtold D; Lee W; Chauhdry S; Palchaudhuri U; Hassoon P; Snell DM; Malpass K; Piers T; Pocock J; Roach A; Smith KJ
Brain; 2013 Apr; 136(Pt 4):1067-82. PubMed ID: 23518709
[TBL] [Abstract][Full Text] [Related]
2. Sodium channels contribute to microglia/macrophage activation and function in EAE and MS.
Craner MJ; Damarjian TG; Liu S; Hains BC; Lo AC; Black JA; Newcombe J; Cuzner ML; Waxman SG
Glia; 2005 Jan; 49(2):220-9. PubMed ID: 15390090
[TBL] [Abstract][Full Text] [Related]
3. Axonal protection using flecainide in experimental autoimmune encephalomyelitis.
Bechtold DA; Kapoor R; Smith KJ
Ann Neurol; 2004 May; 55(5):607-16. PubMed ID: 15122700
[TBL] [Abstract][Full Text] [Related]
4. Neuronal injury in chronic CNS inflammation.
Zindler E; Zipp F
Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotection by safinamide in the 6-hydroxydopamine model of Parkinson's disease.
Sadeghian M; Mullali G; Pocock JM; Piers T; Roach A; Smith KJ
Neuropathol Appl Neurobiol; 2016 Aug; 42(5):423-35. PubMed ID: 26300398
[TBL] [Abstract][Full Text] [Related]
6. Acid-sensing ion channel 1 is involved in both axonal injury and demyelination in multiple sclerosis and its animal model.
Vergo S; Craner MJ; Etzensperger R; Attfield K; Friese MA; Newcombe J; Esiri M; Fugger L
Brain; 2011 Feb; 134(Pt 2):571-84. PubMed ID: 21233144
[TBL] [Abstract][Full Text] [Related]
7. Axonal protection in experimental autoimmune neuritis by the sodium channel blocking agent flecainide.
Bechtold DA; Yue X; Evans RM; Davies M; Gregson NA; Smith KJ
Brain; 2005 Jan; 128(Pt 1):18-28. PubMed ID: 15509620
[TBL] [Abstract][Full Text] [Related]
8. Lesional-targeting of neuroprotection to the inflammatory penumbra in experimental multiple sclerosis.
Al-Izki S; Pryce G; Hankey DJ; Lidster K; von Kutzleben SM; Browne L; Clutterbuck L; Posada C; Edith Chan AW; Amor S; Perkins V; Gerritsen WH; Ummenthum K; Peferoen-Baert R; van der Valk P; Montoya A; Joel SP; Garthwaite J; Giovannoni G; Selwood DL; Baker D
Brain; 2014 Jan; 137(Pt 1):92-108. PubMed ID: 24287115
[TBL] [Abstract][Full Text] [Related]
9. Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation.
Petratos S; Ozturk E; Azari MF; Kenny R; Lee JY; Magee KA; Harvey AR; McDonald C; Taghian K; Moussa L; Mun Aui P; Siatskas C; Litwak S; Fehlings MG; Strittmatter SM; Bernard CC
Brain; 2012 Jun; 135(Pt 6):1794-818. PubMed ID: 22544872
[TBL] [Abstract][Full Text] [Related]
10. Activated microglia mediate axoglial disruption that contributes to axonal injury in multiple sclerosis.
Howell OW; Rundle JL; Garg A; Komada M; Brophy PJ; Reynolds R
J Neuropathol Exp Neurol; 2010 Oct; 69(10):1017-1033. PubMed ID: 20838243
[TBL] [Abstract][Full Text] [Related]
11. Relationship of acute axonal damage, Wallerian degeneration, and clinical disability in multiple sclerosis.
Singh S; Dallenga T; Winkler A; Roemer S; Maruschak B; Siebert H; Brück W; Stadelmann C
J Neuroinflammation; 2017 Mar; 14(1):57. PubMed ID: 28302146
[TBL] [Abstract][Full Text] [Related]
12. MHC gene related effects on microglia and macrophages in experimental autoimmune encephalomyelitis determine the extent of axonal injury.
Storch MK; Weissert R; Steffer A; Birnbacher R; Wallström E; Dahlman I; Ostensson CG; Linington C; Olsson T; Lassmann H
Brain Pathol; 2002 Jul; 12(3):287-99. PubMed ID: 12146797
[TBL] [Abstract][Full Text] [Related]
13. Butylphthalide ameliorates experimental autoimmune encephalomyelitis by suppressing PGAM5-induced necroptosis and inflammation in microglia.
Wang Y; Bi Y; Xia Z; Shi W; Li B; Li B; Chen L; Guo L
Biochem Biophys Res Commun; 2018 Feb; 497(1):80-86. PubMed ID: 29407174
[TBL] [Abstract][Full Text] [Related]
14. Oral administration of the KATP channel opener diazoxide ameliorates disease progression in a murine model of multiple sclerosis.
Virgili N; Espinosa-Parrilla JF; Mancera P; Pastén-Zamorano A; Gimeno-Bayon J; Rodríguez MJ; Mahy N; Pugliese M
J Neuroinflammation; 2011 Nov; 8():149. PubMed ID: 22047130
[TBL] [Abstract][Full Text] [Related]
15. Idazoxan attenuates spinal cord injury by enhanced astrocytic activation and reduced microglial activation in rat experimental autoimmune encephalomyelitis.
Wang XS; Chen YY; Shang XF; Zhu ZG; Chen GQ; Han Z; Shao B; Yang HM; Xu HQ; Chen JF; Zheng RY
Brain Res; 2009 Feb; 1253():198-209. PubMed ID: 19083996
[TBL] [Abstract][Full Text] [Related]
16. Compromised axon initial segment integrity in EAE is preceded by microglial reactivity and contact.
Clark KC; Josephson A; Benusa SD; Hartley RK; Baer M; Thummala S; Joslyn M; Sword BA; Elford H; Oh U; Dilsizoglu-Senol A; Lubetzki C; Davenne M; DeVries GH; Dupree JL
Glia; 2016 Jul; 64(7):1190-209. PubMed ID: 27100937
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotection of axons with phenytoin in experimental allergic encephalomyelitis.
Lo AC; Black JA; Waxman SG
Neuroreport; 2002 Oct; 13(15):1909-12. PubMed ID: 12395089
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotection without immunomodulation is not sufficient to reduce first relapse severity in experimental autoimmune encephalomyelitis.
Hasseldam H; Johansen FF
Neuroimmunomodulation; 2010; 17(4):252-64. PubMed ID: 20203531
[TBL] [Abstract][Full Text] [Related]
19. Post Stroke Safinamide Treatment Attenuates Neurological Damage by Modulating Autophagy and Apoptosis in Experimental Model of Stroke in Rats.
Wasan H; Singh D; Joshi B; Sharma U; Dinda AK; Reeta KH
Mol Neurobiol; 2021 Dec; 58(12):6121-6135. PubMed ID: 34453687
[TBL] [Abstract][Full Text] [Related]
20. Axonal protection achieved in a model of multiple sclerosis using lamotrigine.
Bechtold DA; Miller SJ; Dawson AC; Sun Y; Kapoor R; Berry D; Smith KJ
J Neurol; 2006 Dec; 253(12):1542-51. PubMed ID: 17219031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
